These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24929476)

  • 1. Environmental risk assessment of selected pharmaceuticals in Turkey.
    Oğuz M; Mihçiokur H
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):79-83. PubMed ID: 24929476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.
    Ivanová L; Fáberová M; Mackuľak T; Grabic R; Bodík I
    Environ Res; 2017 May; 155():31-35. PubMed ID: 28183039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden.
    Zorita S; Mårtensson L; Mathiasson L
    Sci Total Environ; 2009 Apr; 407(8):2760-70. PubMed ID: 19157523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorption and degradation of wastewater-associated non-steroidal anti-inflammatory drugs and antibiotics in soils.
    Lin K; Gan J
    Chemosphere; 2011 Apr; 83(3):240-6. PubMed ID: 21247615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use.
    Stuer-Lauridsen F; Birkved M; Hansen LP; Lützhøft HC; Halling-Sørensen B
    Chemosphere; 2000 Apr; 40(7):783-93. PubMed ID: 10705557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
    Christensen AM; Markussen B; Baun A; Halling-Sørensen B
    Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.
    Zhao JL; Ying GG; Liu YS; Chen F; Yang JF; Wang L; Yang XB; Stauber JL; Warne MS
    Environ Toxicol Chem; 2010 Jun; 29(6):1377-84. PubMed ID: 20821582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental risk assessment of antibiotics: an intensive care unit analysis.
    de Souza SM; Vasconcelos EC; Dziedzic M; de Oliveira CM
    Chemosphere; 2009 Nov; 77(7):962-7. PubMed ID: 19744697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment.
    Lin AY; Panchangam SC; Chen HY
    J Environ Monit; 2010 Jan; 12(1):261-70. PubMed ID: 20082021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge.
    Langford KH; Reid M; Thomas KV
    J Environ Monit; 2011 Aug; 13(8):2284-91. PubMed ID: 21725567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective analysis of ibuprofen, ketoprofen and naproxen in wastewater and environmental water samples.
    Hashim NH; Khan SJ
    J Chromatogr A; 2011 Jul; 1218(29):4746-54. PubMed ID: 21645900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment.
    Bound JP; Voulvoulis N
    Water Res; 2006 Aug; 40(15):2885-92. PubMed ID: 16859731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the pharmaceuticals for human use contaminating the Italian aquatic environment.
    Zuccato E; Castiglioni S; Fanelli R
    J Hazard Mater; 2005 Jul; 122(3):205-9. PubMed ID: 15967275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
    Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
    Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
    Jones OA; Voulvoulis N; Lester JN
    Water Res; 2002 Dec; 36(20):5013-22. PubMed ID: 12448549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental impact assessment of pharmaceutical prescriptions: Does location matter?
    Oldenkamp R; Huijbregts MA; Hollander A; Ragas AM
    Chemosphere; 2014 Nov; 115():88-94. PubMed ID: 24508156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of non-steroidal anti-inflammatory and analgesic pharmaceuticals in seawaters of North of Portugal: occurrence and environmental risk.
    Lolić A; Paíga P; Santos LH; Ramos S; Correia M; Delerue-Matos C
    Sci Total Environ; 2015 Mar; 508():240-50. PubMed ID: 25481252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Environ Pollut; 2009 Jun; 157(6):1778-86. PubMed ID: 19299056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.